BRAF and diffuse large B-cell lymphoma: The aberrant activation of the Braf pseudogene, proved to upregulate Braf and downstream MAPK pathways through competitive endogenous RNA mechanisms, was shown to induce B cell lymphoma (DLBCL) in mice [204].